Psilocybin trials for Depression

All Psilocybin trials · All Depression trials

Phase breakdown

Recruiting trials studying Psilocybin for Depression

• A Randomized Neuroimaging Trial of Psilocybin in Depression
  NCT06072898 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · 1 location
• Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
  NCT06706232 · Phase: Phase 2 · Ages: 25 Years to 70 Years · Sex: All (male and female) · 1 location
• Effect of Psilocybin and Structured Integrated Reframing Therapy on Gut-Brain Axis Biomarkers and Depression in Major Depressive Disorder
  NCT07703722 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 3 locations
• Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
  NCT07211438 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Investigation to Understand and Optimize Psilocybin
  NCT06512194 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Open-Label Psilocybin Study in Transdiagnostic Population
  NCT06442423 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
  NCT07226232 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 5 locations
• Psilocybin Therapy for Depression in Parkinson's Disease
  NCT06455293 · Phase: Phase 2 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder
  NCT06592833 · Phase: Phase 2 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Psilocybin as a Novel Therapy for Residual Anhedonia
  NCT07607938 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
  NCT04123314 · Phase: Early Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Psilocybin for Hospitalized Patients with Treatment-resistant Depression
  NCT06378229 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Psilocybin in Chronic Low Back Pain and Depression
  NCT06355414 · Phase: Phase 1 · Ages: 21 Years to 80 Years · Sex: All (male and female) · 1 location
• Psilocybin rTMS for Treatment Resistant Depression
  NCT06132178 · Phase: Phase 2 · Ages: 22 Years to 65 Years · Sex: All (male and female) · 1 location
• Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
  NCT06200155 · Phase: Phase 2 · Ages: 25 Years and older · Sex: All (male and female) · 1 location
• Psilocybin-Assisted Therapy for Intergenerational Trauma
  NCT06899165 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
  NCT07216404 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
  NCT06801041 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
  NCT06247839 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Psilocybin for Depression?

19 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.